Statistics for Oncolytics Biotech Inc (id:13739 ONC)
Valuation metrics
Market cap
108.37M
Enterprise value
89.44M
Trailing P/E (ttm)
-3.34
Forward P/E
-3.36
PEG ratio
-3.36
Price/Sales (ttm)
Price/Book (mrq)
3.81
Enterprise Value/Revenue
Enterprise Value/EBITDA
-2.45
Overview
Shares outstanding
76.86M
Float
73.76M
Shares short
439.37K
% Held by insiders
0.04%
% Held by institutions
0.02%
Average volume (10 days)
89.13K
Average volume (90 days)
Price summary
52-Week low
1.15
52-Week high
2.32
52-Week change
-60.58%
Beta
1.51
50-Day moving average
1.49
200-Day moving average
1.45
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
May 25th, 2018
Ex-dividend date
Last split factor
2:1
Last split date
May 25th, 2018
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
June 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-71.33%
Return on equity
-138.22%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-36,448,000.00
Net income to common (ttm)
-28,024,000.00
Diluted EPS (ttm)
-0.38
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
24.85M
Total cash per share (mrq)
0.32
Total debt (mrq)
1.12M
Total Debt/Equity (mrq)
6.10
Current ratio (mrq)
499.20%
Book value per share (mrq)
0.37
Cash flow
Cash flow statement
-26,442,000.00
Levered free cash flow (LFCF)
-15,766,375.00